BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 15041478)

  • 1. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
    van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
    Diah SK; Smitherman PK; Townsend AJ; Morrow CS
    Toxicol Appl Pharmacol; 1999 Jun; 157(2):85-93. PubMed ID: 10366541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
    van Zanden JJ; Wortelboer HM; Bijlsma S; Punt A; Usta M; Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2005 Feb; 69(4):699-708. PubMed ID: 15670588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin.
    van Zanden JJ; de Mul A; Wortelboer HM; Usta M; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2005 Jun; 69(11):1657-65. PubMed ID: 15896345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
    Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
    Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
    Priebe W; Krawczyk M; Kuo MT; Yamane Y; Savaraj N; Ishikawa T
    Biochem Biophys Res Commun; 1998 Jun; 247(3):859-63. PubMed ID: 9647783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.
    Wortelboer HM; Usta M; van Zanden JJ; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2005 Jun; 69(12):1879-90. PubMed ID: 15885658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
    Vaidya SS; Walsh SW; Gerk PM
    Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of glutathione conjugation and conjugate efflux in detoxification of the carcinogen, 4-nitroquinoline 1-oxide: contributions of glutathione, glutathione S-transferase, and MRP1.
    Peklak-Scott C; Townsend AJ; Morrow CS
    Biochemistry; 2005 Mar; 44(11):4426-33. PubMed ID: 15766272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required.
    Leslie EM; Haimeur A; Waalkes MP
    J Biol Chem; 2004 Jul; 279(31):32700-8. PubMed ID: 15161912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells.
    Morrow CS; Smitherman PK; Townsend AJ
    Mol Carcinog; 2000 Nov; 29(3):170-8. PubMed ID: 11108662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
    Paumi CM; Wright M; Townsend AJ; Morrow CS
    Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential.
    van Zanden JJ; van der Woude H; Vaessen J; Usta M; Wortelboer HM; Cnubben NH; Rietjens IM
    Biochem Pharmacol; 2007 Jul; 74(2):345-51. PubMed ID: 17509533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity.
    Smitherman PK; Townsend AJ; Kute TE; Morrow CS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):260-7. PubMed ID: 14569069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
    Leslie EM; Mao Q; Oleschuk CJ; Deeley RG; Cole SP
    Mol Pharmacol; 2001 May; 59(5):1171-80. PubMed ID: 11306701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane.
    Sibhatu MB; Smitherman PK; Townsend AJ; Morrow CS
    Carcinogenesis; 2008 Apr; 29(4):807-15. PubMed ID: 18204073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.
    Peklak-Scott C; Smitherman PK; Townsend AJ; Morrow CS
    Mol Cancer Ther; 2008 Oct; 7(10):3247-55. PubMed ID: 18852128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.
    Diah SK; Smitherman PK; Aldridge J; Volk EL; Schneider E; Townsend AJ; Morrow CS
    Cancer Res; 2001 Jul; 61(14):5461-7. PubMed ID: 11454692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.